April Baisden
Psychiatry · Scott Depot, WVNPI 1376763144
Payments from drug & device makers
Across 893 payments — averaging $867.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$724K
- Vanda Pharmaceuticals Inc.$50K
- Alkermes, Inc.$262
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$194
- Axsome Therapeutics, Inc.$165
- Neurocrine Biosciences, Inc.$93
- plus $645 from 14 others
What the payments were for
- Speaking & faculty fees$720,78393%
- Travel & lodging$41,8655%
- Food & beverage$12,2382%
- Education$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 757 | $724,044 |
| Vanda Pharmaceuticals Inc. | 61 | $49,509 |
| Alkermes, Inc. | 21 | $262 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $194 |
| Axsome Therapeutics, Inc. | 8 | $165 |
| Neurocrine Biosciences, Inc. | 5 | $93 |
| Novo Nordisk | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| Lundbeck LLC | 3 | $66 |
| Indivior Inc. | 3 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $41 |
| Exact Sciences | 2 | $40 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$774,912 in reported general payments places this provider in the 95th percentile of 177 psychiatry providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 15 | $158,951 |
| VraylarCariprazine Hcl | 64 | $88,659 |
| VivitrolNaltrexone Microspheres | 12 | $19,108 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 193 | $18,384 |
| Lurasidone Hcl | 18 | $9,720 |
| Atomoxetine Hcl | 12 | $2,494 |
| Duloxetine Hcl | 60 | $1,164 |
| Mirtazapine | 51 | $1,014 |
| Aripiprazole | 41 | $922 |
| Fluvoxamine Maleate | 15 | $816 |
| Quetiapine Fumarate | 46 | $695 |
| Bupropion XlBupropion Hcl | 19 | $687 |
| Lamotrigine | 38 | $549 |
| Alprazolam | 70 | $486 |
| Oxcarbazepine | 11 | $480 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $93 | $158,95115 claims |
| AbbVieVraylar | $724,044 | $88,65964 claims |
| Alkermes, Inc.Vivitrol | $262 | $19,10812 claims |
| Lilly USA, LLCOlanzapine | $18 | $33529 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 177 psychiatry providers in West Virginia.
Other psychiatry in Scott Depot
- Melissa MoodyCharleston$1.2M
- Ryan WakimWheeling$772K
- Daniel ThistlethwaiteSouth Charleston$468K
- Walter ByrdMorgantown$299K
- Fahd MousaCharleston$200K
- Debra StultzBarboursville$176K
- Shahnoor KhanMartinsburg$161K
- Ahmed FaheemBeckley$82K
- Suzanne HolroydHuntington$67K
- Steve CorderWheeling$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.